Table 8 QTLs for IV and fatty acid composition found to be significant using MQM mapping and Kruskal-Wallis analysis
Trait | Co-Factor | Group | LOD Peak | Position of LOD peak (cM) | Left – Right Locus a | % variance explained | Kruskal-Wallis test (P) |
|---|---|---|---|---|---|---|---|
IV | EAGG/MCAT-198 | 1 | 9.55 | 132.4 | CB75A(-) - EAGG/MCAT-198(-) | 46.3 | 0.0001 0.0001 |
C14:0 | EAAC/MCAC-133 | 15 | 5.30 | 4.8 | P4T8(-) - EAAG/MCAT-221(-) | 20.5 | 0.0001 0.0001 |
| Â | & EAAG/MCAT-221 | 1 | 4.63 | 137.4 | CB75A(+) - EAGG/MCAT-198(+) | 13.1 | 0.010 0.005 |
C16:0 | EAGG/MCAT-198 | 1 | 8.92 | 132.4 | CB75A(+) - EAGG/MCAT-198(+) | 44.4 | 0.0001 0.0001 |
C16:1 | EAAG/MCAT-221 | 15 | 13.26 | 7.7 | P4T8(-) - EAAG/MCAT-221(-) | 55.8 | 0.0001 0.0001 |
C18:0 | EAAG/MCAT-221 | 15 | 5.10 | 6.9 | P4T8(+) - EAAG/MCAT-221(+) | 23.2 | 0.0001 0.0005 |
| Â | Â | 1 | 3.79 | 132.4 | CB75A(+) - EAGG/MCAT-198(+) | 17.2 | 0.0050 0.0005 |
| Â | Â | 3 | 3.24 | 75.9 | TAGC/HCAG > 330(+) - | 16.3 | 0.005 |
| Â | Â | Â | Â | Â | - | Â | Â |
C18:1 | EAGG/MCAT-198 | 1 | 6.59 | 133.4 | CB75A(-) - EAGG/MCAT-198(-) | 33.1 | 0.0001 0.0001 |
| Â | Â | 15 | 3.04 | 7.7 | P4T8(+) - EAAG/MCAT-221(+) | 12.8 | 0.010 0.010 |
C18:2 | EAAG/MCAC-173 | 2 | 3.54 | 34.4 | EAGG/MCAC175(+)- EAAG/MCAC-173(+) | 19.7 | 0.0010 0.0005 |